We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
5-alpha reductase inhibitors and erectile dysfunction: the connection.
- Authors
Erdemir, Fikret; Harbin, Andrew; Hellstrom, Wayne J G
- Abstract
Benign prostatic hyperplasia (BPH) is a common problem affecting middle-aged and elderly men. First-line medical therapy includes alpha 1blockers and 5alpha-reductase inhibitors (5ARIs), such as finasteride and dutasteride. 5ARI use has been associated with adverse sexual outcomes, including erectile dysfunction (ED), ejaculatory dysfunction (EjD), and decreased libido.
- Publication
The journal of sexual medicine, 2008, Vol 5, Issue 12, p2917
- ISSN
1743-6109
- Publication type
Journal Article
- DOI
10.1111/j.1743-6109.2008.01001.x